VESICURE THERAPEUTICS
VesiCURE Therapeutics engages in the research and development of exosome innovative drugs. The company focuses on the research and development of exosomal (extracellular vesicles, EV) drugs, promoting the establishment and improvement of the exosomal pharmaceutical industry chain. The company was founded in 2021and is based in Suzhou, Jiangsu, China.
VESICURE THERAPEUTICS
Social Links:
Industry:
Health Care Medical Pharmaceutical
Founded:
2021-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.vesicure.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Euro Font Awesome Pound Sterling Japanese Yen Unified Layer
Similar Organizations
Ab&B Biotech
Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.
BioLeaders
BioLeaders is an innovative technology for future global healthcare group
Cell Products of National Engineering Research Center
Cell Products of National Engineering Research Center engages in the research and development of cell therapeutic products.
Evergreen Therapeutics
Evergreen Therapeutics engages in the research and development of clinical drugs in the field of immunity and ophthalmology.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Haina Pharmaceuticals
Haina Pharmaceuticals engages in the research and development of drugs, biological sample testing, and drug registration.
Huvet Bio
Huvet Bio is engaged in the research and development of bio pharmaceuticals.
QureBio
QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals.
Regenex Corporation
Regenex Corporation engages in the reproductive health drug development business.
Weihe Pharma
Weihe Pharma engages in the research and development of natural herbal medicines.
Investors List
Northern Light Venture Capital
Northern Light Venture Capital investment in Venture Round - VesiCURE Therapeutics
BioVenture
BioVenture investment in Venture Round - VesiCURE Therapeutics
Official Site Inspections
http://www.vesicure.com Semrush global rank: 9.01 M Semrush visits lastest month: 445
- Host name: box5760.bluehost.com
- IP address: 162.241.253.30
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "VesiCURE Therapeutics"
VesiCURE Therapeutics - Crunchbase Company Profile …
VesiCURE Therapeutics engages in the research and development of exosome innovative drugs. The company focuses on the research and development of exosomal (extracellular vesicles, EV) drugs, promoting the establishment and …See details»
VesiCURE Therapeutics
除了传统的小分子化学药物以外，大分子蛋白质药物、核酸类药物、基因疗法、细胞疗法、以及在此基础上的多功能复合疗法等等全新的平台逐渐成为创新药研发领域关注的重点。 在药物递 …See details»
About – VesiCURE Therapeutics
仰时代发展、借地缘便捷、聚人才荟萃，以科技为先、民生为本，构建国内首创的外泌体（Extracellular Vesicles，EV）创新药研发平台 –. 唯思尔康已完成亿元级天使轮融资，并完 …See details»
Viecure | Halo Intelligence | Greenwood Village
“VieCure is a platform built for the modern era of community oncology care. With the burden of physicians and clinical staff increasing, having software tools that assist you in your day-to-day workflows is critical. VieCure’s comprehensive …See details»
Vesicure
MEVs are a cell-based therapy for ovarian cancer maintenance treatment.See details»
VesiCURE Therapeutics Co., Ltd. - Drug pipelines, Patents, Clinical ...
Vesicure Therapeutics, a biotech company from Suzhou China, recently introduced their exosome-based siRNA delivery platform in a proof-of-concept study, by efficiently shuttling cell …See details»
Ke Xu - Founder, Chairman and CEO - VesiCURE …
Sep 16, 2016 · Leading and coordinating research groups focusing on Exosome Biology, Tissue Tropism, Targeted Delivery, Gene therapy, Stem Cells (HESC/iPSC), immuno-oncology and vaccines. CRISPR/Cas9 and TALEN...See details»
VesiCURE Therapeutics - Contacts, Employees, Board Members
VesiCURE Therapeutics engages in the research and development of exosome innovative drugs.See details»
Exosomes functionally deliver siRNAs in vivo to repress tumor …
Sep 5, 2023 · In this manuscript, the VesiCURE team introduced their proprietary exosome-based technology called "dilEVry" and demonstrated its capability for effective functional siRNA …See details»
MDX-101 (VesiCURE) - Drug Targets, Indications, Patents
MDX-101 (VesiCURE), Initially developed by VesiCURE Therapeutics Co., Ltd., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms, Active Indication: Solid …See details»
Vesicure Announces Positive Early Results of Exosome Technology …
Jan 29, 2024 · Suzhou Vesicure Therapeutics, a company developing exosomes to deliver siRNA drugs, announced that its extracellular vesicles (EVs) successfully carried siRNA cargo …See details»
Guidelines for clinical translation and commercialization of ...
Dec 1, 2023 · Extracellular vesicles (EVs) are lipid-bilayer delimited membrane structures released by cells, and play a role in intercell communication and disease development. The …See details»
Vesicure Therapeutics made notable advancements using
Jan 29, 2024 · Vesicure Therapeutics, a biotech company from Suzhou China, recently introduced their exosome-based siRNA delivery platform in a proof-of-concept study, by efficiently …See details»
Therapeutic targeting of KRAS mutation-driven tumorigenesis by ...
Jan 20, 2024 · Here, we explored the potential of extracellular vesicles (EVs) for therapeutic targeting of KRAS mutation-driven tumorigenesis. EVs loaded with small interfering RNA …See details»
Harnessing extracellular vesicles for efficient siRNA ... - bioRxiv
Aug 27, 2023 · Extracellular vesicles (EVs) are endogenous, cell secreted nano-vehicles which have been explored for functional siRNA delivery, yet impurities in EVs preparation and lack of …See details»
Harnessing extracellular vesicles for efficient siRNA
Aug 26, 2023 · Extracellular vesicles (EVs) are endogenous, cell secreted nano-vehicles which have been explored for functional siRNA delivery, yet impurities in EVs preparation and lack of …See details»
Vesicure Therapeutics made notable advancements using …
Jan 29, 2024 · Vesicure Therapeutics, a biotech company from Suzhou China, recently introduced their exosome-based siRNA delivery platform in a proof-of-concept study, by efficiently …See details»
Solifenacin - Wikipedia
Solifenacin, sold as the brand name Vesicare[a] among others, is a medicine used to treat overactive bladder and neurogenic detrusor overactivity (NDO). [1][2] It may help with …See details»
A New Large-Scale Extracellular Vesicle Production Strategy for ...
Apr 19, 2024 · Herein, we introduce a novel large-scale EV production strategy, including an upstream process with fed-batch suspension HEK293 cell culture, and a downstream process …See details»
Vesicare Uses, Dosage, & Side Effects - Drugs.com
VESIcare is a prescription medicine used to treat symptoms of overactive bladder, such as frequent or urgent urination, and incontinence (urine leakage).See details»